We studied the pharmacokinetics of cefaclor, a new cephalosporin antibiotic, in normal subjects and subjects with chronic renal failure. Cefaclor was largely, but not entirely, eliminated by the kidneys. The cefaclor half-life in normal subjects was 40 to 60 min; in subjects with essentially no renal function, it increased to 3 h. In normal subjects, 50 to 70% of a 250-mg dose was excreted in the urine within 8 h. The linear relationship between the elimination constant and creatinine clearance allowed the construction of a useful dosage modification nomogram.
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Cefaclor, 3-chloro-7-D-(2-phenylglycinamido)-3-cephem-4-carboxylic acid, is an orally absorbed, cephalosporin antibiotic that has a wide range of antibacterial activity against both gram-positive and gram-negative species (6) . Pharmacokinetic data obtained from normal human volunteers indicate that cefaclor is rapidly absorbed when given orally (Cefaclor, Clinical Investigational Manual, Lilly Research Laboratories, Eli Lilly & Co., May 1976). The drug is eliminated from the plasma via the kidneys in 4 to 6 h and has a plasma halflife (Ti) of 40 to 45 min. The present study was performed to examine the pharmacokinetics of cefaclor in patients with diminished renal function. Guidelines for the use of cefaclor in patients with renal failure were formulated.
MATERIALS AND METHODS
Twenty-five subjects were selected for the study after informed consent was obtained. Sixteen had underlying chronic renal disease (creatinine clearance rate [Ccr] , 0 to 59 ml/min). Three were older persons whose renal function (Ccr, 81 to 87 ml/min) was appropriate for their age. Six were young, healthy volunteers (Ccr, 93 to 125 ml/min). Five of the sixteen subjects with chronic renal disease required hemodialysis. The subjects' renal function is outlined in Table 1 .
After a single 250-mg oral dose, blood specimens for plasma concentrations were obtained at 0.5, 1, 2, 3, 4, 5, 6, 7 and 8 h. During that 8-h period, a urine specimen was collected from each of the nondialysis patients, which was analyzed for cefaclor concentration as well as Cer.
Since Table 1 outlines the subject population, their renal function, and the drug elimination data.
RESULTS
The Ti ranged from less than 1 h in normal subjects to 3 h in the subjects requiring intermittent hemodialysis. The relationship between the Ccr and the Ti was hyperbolic and best fit the expression: T1 = 4.88 Cer-0637. The plasma creatinine rate (Pcr) and Ti were directly correlated (r = 0.72, P < 0.05). By least squares regression, the line of best fit was defined by the expression: Ti = 0.224 Pcr + 0.821. The Ke and Ccr were directly correlated as well (r = 0.78, P < 0.05). A linear relationship was assumed, which was defined by the expression: Ke = 0.00717 Cc, + 0.24011 (Fig. 1) . The relationship between the Ke and Pcr was hyperbolic and best fit the expression: Ke = 0.994 Pcr4m. The amount of cefaclor appearing in urine within the 8-h period of administration was correlated directly with the Ocr (r = 0.71, P < 0.05).
PHARMACOKINETICS OF CEFACLOR

DISCUSSION
The data indicate that in humans the elimination of cefaclor is primarily dependent on renal function. Such is also the case in mice and rats (6) . Biliary excretion of cefaclor has been observed in mice as well. In dogs however, cefaclor is labile to metabolism, and only a small amount is excreted unchanged in the urine (6) . In our normal subjects, about 50 to 70% of cefaclor was recovered in the urine after 8 h.
The linear relationship between the Ke of cefaclor and the 2cr allowed for construction of a useful nomogram for use of the compound in patients with diminished renal function (Fig.  1) 
